Faster insulin in pumps may improve after-meal blood sugar in kids with diabetes
NCT ID NCT04149262
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a faster-acting insulin (Fiasp) works better than standard rapid insulin (NovoRapid) in insulin pumps for children and teens with type 1 diabetes. Researchers looked at blood sugar levels 30 minutes, 1 hour, and 2 hours after meals using real-world data from 44 participants. The goal was to see if the faster insulin leads to better post-meal glucose control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fast-acting insulin aspart (Fiasp)
What this could lead to
If it works, this could show that faster-acting insulin helps control blood sugar better after meals in children with type 1 diabetes using insulin pumps.
What could go wrong
This is a small, completed study with only 44 participants, so results may not apply to all children. It also looks at short-term glucose levels, not long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aristotle University of Thessaloniki
Thessaloniki, 54246, Greece